New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For CI;WCG;HNT;MOH;UNH;CVH;WLP;AGP;CNC;HS;HUM;AET;MDT;BSX;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
October 1, 2014
08:08 EDTCICigna management to meet with Deutsche Bank
Subscribe for More Information
07:45 EDTMDTMedtronic has upside in multiple scenarios, says BofA/Merrill
Subscribe for More Information
September 30, 2014
10:02 EDTMDT, STJ, BSXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTAETAetna and Seton Health Allicen form collaboratoin in Austin
Aetna and Seton Health Alliance announced an accountable care collaboration and the introduction of Aetna Whole Health in Austin. The plans will be effective for self-insured customers on October 1, 2014, and in early 2015 for fully insured members.
09:07 EDTUNHUnitedHealth's Optum to acquire MedSynergies
Optum, part of UnitedHealth, announced it has entered into a definitive agreement to acquire MedSynergies, Inc., which provides physician practice management, revenue management, physician referral management and other business services to physician groups aligned with large health systems, serving more than 9,300 care providers across the U.S. The transaction is subject to regulatory approval and other customary closing conditions.
07:48 EDTWLPLeerink to hold a roundtable
Subscribe for More Information
07:34 EDTCICigna management to meet with Deutsche Bank
Meeting to be held in Frankfurt on September 30 hosted by Deutsche Bank.
06:57 EDTSTJSt. Jude Medical initiated with a Strong Buy at Needham
Subscribe for More Information
06:57 EDTMDTMedtronic initiated with a Buy at Needham
Subscribe for More Information
06:56 EDTBSXBoston Scientific initiated with a Hold at Needham
September 29, 2014
13:28 EDTHUMHumana announces health application integration with Apple's HealthKit
Subscribe for More Information
09:31 EDTAETAetna, HHC announce new multi-year network agreement
Aetna and Hartford HealthCare announced a new multi-year network agreement beginning on January 1, 2015, and that the two organizations will offer new value-based, accountable care arrangements in Connecticut beginning next year. Aetna and Hartford HealthCare plan to implement an accountable care agreement for Aetna members beginning in 2015 and to jointly introduce new accountable care products in 2016. The accountable care agreement is designed to improve quality and the overall patient experience, improve access to care, and lower medical costs. Integrated Care Partners will play a critical role in improving how patient care is delivered through the new value-based accountable care relationships that are being defined. In an accountable care agreement, a group of health care providers assumes responsibility for the quality and cost of care for a group of patients. Aetna members in these models receive an enhanced level of coordinated care in addition to the member benefits of their current Aetna plan.
08:22 EDTCICigna management to meet with Deutsche Bank
Subscribe for More Information
06:58 EDTMDTU.S. tax regulations may require Medtronic-Covidien renegotiations, Reuters says
Subscribe for More Information
September 26, 2014
16:55 EDTMDTMarket ends week lower after inversion crackdown, mixed data
Subscribe for More Information
September 25, 2014
09:00 EDTHNTSterne Agee confident in Street high estimates for Health Net
Sterne Agee is confident in its Street high estimates for Health Net (HNT) following management meetings.. The analyst maintains its FY EPS estimate of $4.64 vs. consensus of $3.21 based on positive exchange utilization patterns, promising Duals results, and the outsourcing agreement with Cognizant.
08:51 EDTMDTMedtronic deal for Covidien still attractive despite new rules, says Bernstein
Bernstein believes that Medtronic's (MDT) deal to acquire Covidien (COV) is still attractive despite the new Treasury rules on tax inversions and the firm thinks the acquisition will still be completed. The firm estimates the transaction would still be 4% cash accretive in FY16 and 9% accretive in FY17 if Medtronic raises debt to fully finance the cash portion of the deal. Bernstein maintains its Outperform rating on Medtronic.
September 24, 2014
16:41 EDTBSXCourt says Boston Scientific breached license agreement
Boston Scientific disclosed in a regulatory filing that on September 24, following a jury verdict against Boston Scientific Corporation, the Montgomery County Circuit Court in Maryland entered a judgment that the company breached its license agreement with Mirowski Family Ventures and awarded damages of $308M. The company believes the facts and the law do not support the jury’s findings or the amount of the damages. The company plans to seek to overturn the judgment in post-trial motions with the Circuit Court and, if necessary, through the appeals process.
09:11 EDTMDTSummer Street Director of Research to hold an analyst/industry conference call
Subscribe for More Information
06:45 EDTHNT, CNC, HS, CI, WLP, WCG, AET, UNH, AGP, MOH, HUMGovernment says more health insurers to enter exchanges in 2015, NY Times says
Subscribe for More Information
06:23 EDTMDTExperts see new tax rules not halting inversions, WSJ reports
Subscribe for More Information
September 23, 2014
16:20 EDTMDTOn The Fly: Closing Wrap
Stocks on Wall Street were lower after the U.S. took new action to clamp down on tax inversion deals and led airstrikes against Islamic State militants in Syria, while Europe reported weaker than expected manufacturing data. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for an increase of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. In China, HSBC's flash manufacturing PMI rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady with its 52.5 reading for August. COMPANY NEWS: The shares of a number of companies that have announced or been speculated as targets in tax inversion deals fell after the U.S. Treasury last night issued new regulations that will make such deals less attractive. AstraZeneca (AZN), which has previously turned down an offer to be acquired by the U.S.'s Pfizer (PFE), sank $3.54, or 4.74%, to $71.13 despite a Bloomberg report that said Pfizer is still considering pursuing a deal with the U.K. drugmaker. AbbVie (ABBV), which has a deal in progress to acquire Shire (SHPG) and thus move its tax domicile to Ireland, fell $1.15, or 1.96%, to $57.56, while Shire shares slid $5.56, or 2.17%, to $250.74. Medtronic (MDT), which is pursuing its own inversion deal with Covidien (COV), dropped $1.90, or 2.88%, to $64.08. MAJOR MOVERS: Among the notable gainers was Herbalife (HLF), which rose $3.88, or 9.65%, to $44.09, bouncing back from a pullback yesterday that had been attributed to rumors of Carl Icahn selling out of his stake in the company. Also higher was Plug Power (PLUG), which rose 40c, or 9.57%, to $4.58 after the company's CEO gave FY15 revenue guidance that was above the consensus Street view in an interview with the Albany Business Review. Among the noteworthy losers was Ascena Retail (ASNA), which dropped $2.78, or 16.82%, to $13.75 after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower were shares of used car retailer CarMax (KMX), which fell $5.01, or 9.49%, to $47.80 after the company reported sluggish comparable used car sales in its second quarter. INDEXES: The Dow declined 116.81, or 0.68%, to 17,055.87, the Nasdaq dropped 19.00, or 0.42%, to 4,508.69, and the S&P 500 fell 11.52, or 0.58%, to 1,982.77.
16:09 EDTBSXBoston Scientific enrolls first patients in U.S. trial of Lotus Valve System
Boston Scientific has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and effectiveness of the Lotus Valve System in patients with severe aortic stenosis and who are considered to be at either high or extreme risk for surgical valve replacement. The Lotus Valve System is the first transcatheter aortic valve replacement device that is both fully repositionable and retrievable prior to release. The primary endpoints of the study are Safety; composite of all-cause mortality, stroke, life-threatening and major bleeding events, stage two or three acute kidney injury or major vascular complications at 30 days. Efficacy; composite of all-cause mortality, disabling stroke or moderate or greater paravalvular aortic regurgitation at one year following procedure.
12:11 EDTMDTOn The Fly: Midday Wrap
Stocks on Wall Street were mixed and little changed at midday, amid new rules from the Obama administration on tax inversions and manufacturing data from around the globe. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for a rise of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. The Richmond Fed manufacturing index for September rose to 14, beating expectations for it to have dropped two points to 10. In China, HSBC's flash manufacturing Purchasing Managers' Index rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady at the 52.5 seen in August. COMPANY NEWS: Shares of several companies, including a number in the pharmaceutical industry, are lower in early trading after the Treasury Department announced new regulations yesterday night that aim to make it tougher for U.S. companies to lower their tax burdens via mergers with foreign companies, otherwise known as "inversions." Among the stocks that moved lower after the new rules were announced was Astrazeneca (AZN), which had previously been a target of Pfizer (PFE) and fell about 4% near midday. Also lower were shares of both Shire (SHPG), which fell 2%, and Abbvie (ABBV), which dropped 1.6%, as the two have previously agreed to merge in a tax inversion deal. Medtronic (MDT) and Covidien (COV), which similarly agreed to an inversion merger, were down 3.3% and 2.7%, respectively. MAJOR MOVERS: Among the notable gainers was Salix Pharmaceuticals (SLXP), which rose more than 5% after The Wall Street Journal reported that Allergan (AGN) is in advanced talks on a deal to buy the company. Shares of Allergan were also up nearly 3% near midday, as the Journal also reported that Allergan rejected a recent buyout offer from Actavis (ACT). Among the noteworthy losers was Ascena Retail (ASNA), which dropped 16% after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower following its own earnings report was auto retailer CarMax (KMX), which fell over 9%. INDEXES: Near midday, the Dow was down 32.91, or 0.19%, to 17,139.77, the Nasdaq was up 2.90, or 0.06%, to 4,530.59, and the S&P 500 was down 2.29, or 0.11%, to 1,992.00.
11:34 EDTMDTMedtronic moves lower as Treasury seeks to curb inversions
Subscribe for More Information
11:19 EDTCICigna, Virginia Quality Care Partners announce collaboration
Subscribe for More Information
10:54 EDTMDTStocks, analysts react to Treasury inversion crackdown
Subscribe for More Information
09:45 EDTSTJ, MDTLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy discusses the ultimate market opportunity for leadless pacers and compares Medtronic vs St. Jude Medical on an Analyst/Industry conference call to be held on September 24 at 2 pm.
09:13 EDTMDTOn The Fly: Pre-market Movers
Subscribe for More Information
08:53 EDTMDTInversion regulations look more onerous than expected, says FBR Capital
FBR Capital says the new regulations announced last night by the Treasury and IRS contain appear more onerous than expected. FBR points out the proposed changes remove the ability of inverting companies to make "hopscotch loans" between the foreign and domestic subsidiaries. The firm believes the regulations will not end the practice of inversions, and it still expects completion of already announced deals.
08:07 EDTUNHFDA Pediatric Advisory Committee to hold a meeting
Subscribe for More Information
07:05 EDTMDTMedtronic will still pursue Covidien deal, says Citigroup
Subscribe for More Information
05:56 EDTMDTTreasury, IRS announce plans to reduce inversion tax benefits
Subscribe for More Information
September 22, 2014
10:15 EDTAETOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Actavis (ACT) downgraded to Equal Weight from Overweight at Barclays... Aetna (AET) downgraded to Neutral from Buy at BofA/Merrill... Auxilium (AUXL) downgraded to Hold from Buy at Stifel... CARBO Ceramics (CRR) downgraded to Neutral from Buy at Sterne Agee... Commerzbank (CRZBY) downgraded to Underperform from Neutral at Exane BNP Paribas... Concur (CNQR) downgraded to Neutral from Buy at Nomura... Dresser-Rand (DRC) downgraded to Neutral from Accumulate at Global Hunter... Finish Line (FINL) downgraded to Equal Weight from Overweight at Morgan Stanley... General Communications (GNCMA) downgraded to Hold from Buy at Drexel Hamilton... InvenSense (INVN) downgraded to Neutral from Outperform at RW Baird... Las Vegas Sands (LVS) downgraded to Market Perform from Outperform at Wells Fargo... Lindsay Corp. (LNN) downgraded at Sterne Agee... Melco Crown (MPEL) downgraded to Market Perform from Outperform at Wells Fargo... Outerwall (OUTR) downgraded to Sell from Neutral at B. Riley... PSEG (PEG) downgraded to Hold from Buy at Jefferies... Realogy (RLGY) downgraded to Underperform from Neutral at Credit Suisse... Regal-Beloit (RBC) downgraded to Accumulate from Buy at Global Hunter... SABMiller (SBMRY) downgraded to Market Perform from Outperform at Bernstein... Saba Software (SABA) downgraded to Neutral from Buy at B. Riley... Suburban Propane (SPH) downgraded to Market Perform from Outperform at Wells Fargo... Swiss Re (SSREY) downgraded to Underperform from Neutral at Exane BNP Paribas... Towers Watson (TW) downgraded to Buy from Conviction Buy at Goldman... Valmont (VMI) downgraded at Sterne Agee... Walgreen (WAG) downgraded to Equal Weight from Overweight at Barclays... Watts Water (WTS) downgraded to Neutral from Buy at Janney Capital... Wynn Resorts (WYNN) downgraded to Market Perform from Outperform at Wells Fargo... Yahoo (YHOO) downgraded to Neutral from Buy at BofA/Merrill.
10:15 EDTWLPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:32 EDTMDTMedtronic announces CE Mark, European launch for TYRX envelope
Medtronic has received CE, or Conformité Européenne, Mark for the TYRX Absorbable Antibacterial Envelope, which covers an implantable cardiac device to help stabilize the device after implantation and reduce surgical-site infections.
09:02 EDTAETAetna downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
09:02 EDTWLPWellPoint upgraded to Buy from Neutral at BofA/Merrill
Subscribe for More Information
08:32 EDTSTJSt. Jude receives CE Mark approval of Tendril STS, IsoFlex Optim labeling
Subscribe for More Information
07:40 EDTWCGWellCare Medicare Advantage margin outlook concerning, says Wedbush
Subscribe for More Information
06:54 EDTCICigna removed from short-term buy list at Deutsche Bank
Subscribe for More Information
06:51 EDTSTJSt. Jude Medical recent weakness a buying opportunity, says Barclays
Barclays said St. Jude Medical weakness is a buying opportunity. The analyst said CardioMEMS is underappreciated by the Street and valuation compelling given sequential revenue growth. Shares are Overweight rated.
September 19, 2014
11:25 EDTMDTSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
06:49 EDTAET, AGP, HUM, WCG, HNT, HS, WLP, MOH, CNC, CI, UNHGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
September 18, 2014
12:18 EDTMDTNY AG announces national settlement with Medtronic for Medicaid violations
Attorney General Eric T. Schneiderman announced that 46 states and the District of Columbia have reach a settlement agreement with Minnesota-based company Medtronic to resolve claims under the False Claims Act that Medtronic improperly induced physicians to recommend Medtronic devices to treat cardiac rhythmic disease. New York led a national team composed of members from Oregon, Texas and California to negotiate the settlement. The federal government settled its matter in May of this year...The agreement requires Medtronic to pay the settling states $362,362, which will go to those states’ Medicaid programs. The matter was brought by a whistleblower, Adolfo Schroeder, and was filed in U.S. District Court for the Eastern District of California. The Attorney General would like to thank Mr. Schroeder for bringing this matter to the government’s attention. Under the terms of the agreement, the New York Medicaid Program will receive $67,369.31. Reference Link
07:52 EDTCNCCentene subsidiary Sunshine Health awarded Commendable Accreditation from NCQA
Subscribe for More Information
September 17, 2014
15:41 EDTWLP, UNHUnitedHealth to replace WellPoint as Georgia SHBP provider, says Deutsche Bank
Subscribe for More Information
14:54 EDTHNTHealth Net management to meet with Sterne Agee
Field trip to company headquarters to be held in Woodland Hills, CA on September 23 hosted by Sterne Agee.
14:43 EDTWLP, UNHUnitedHealth to replace WellPoint as Georgia SHBP provider, says Deutsche Bank
Subscribe for More Information
10:00 EDTCIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
09:08 EDTMDTMedtronic launches new Balloon Kyphoplasty Platform
Subscribe for More Information
08:38 EDTCICigna upgraded to Positive from Neutral at Susquehanna
As previously reported, Susquehanna upgraded Cigna to Positive from Neutral. The firm believes Cigna's earnings are poised to accelerate driven by a reduction in ACA related losses, conservative medical cost ratio assumptions, buybacks, and normal business growth. Price target raised to $115 from $77.
07:43 EDTBSX, MDTBofA/Merrill to hold a conference
Subscribe for More Information
07:06 EDTCICigna upgraded to Positive from Neutral at Susquehanna
06:09 EDTMDTIntegra LifeSciences to acquire Medtronic instrumentation lines for $60M
Integra LifeSciences (IART) and Medtronic (MDT) announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines for approximately $60M in cash. Integra expects the transaction to close in Q4. Integra will acquire a portfolio of approximately 4,000 MicroFrance and Xomed manual ENT and laparoscopic surgical instruments, as well as the St. Aubin le Monial, France manufacturing facility. Sales from the products being acquired totaled approximately $30M, two-thirds of which were generated outside the U.S. Integra expects to record approximately $27M-$30M in revenue and approximately 10c of adjusted EPS in calendar 2015 from this acquisition. The earnings accretion should rise after the first year once certain sales transitions are complete. The company expects the acquisition to contribute less than $5M in revenue and be neutral to earnings in Q4. The transition and integration is expected to be completed by 2H15.
05:09 EDTBSXBoston Scientific receives CE Mark for Vercise DBS system
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use